Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesViruses associated with human cancerRole of mTOR Inhibitors in Kidney DiseasePlace of mTOR inhibitors in management of BKV infection after kidney transplantationBK polyoma virus infection and renal disease in non-renal solid organ transplantationDifferent behaviour of BK-virus infection in liver transplant recipientsPolyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imagingUnraveling the Role of Allo-Antibodies and Transplant InjuryBK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infectionReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesThe Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ TransplantationThe impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantationLeflunomide: a drug with a potential beyond rheumatologyGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveAn MHC class Ib-restricted CD8 T cell response confers antiviral immunitySystematic screening of BK virus by real-time PCR prevents BK virus associated nephropathy in renal transplant recipients.Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.Increased prevalence of polyomavirus BK viruria that correlates with thrombocytopenia in patients with systemic lupus erythematosus on intensive immunosuppressive therapy.A rare case of hemorrhagic cystitis complicated with thrombocytopenia and hemophagocytic syndrome associated with BK virus, under immunosuppressive treatment of systemic lupus erythematosus.Lipid, blood pressure and kidney update 2013.Global effects of BKV infection on gene expression in human primary kidney epithelial cells.Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients.Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft RejectionPre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityA delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipientsIncidence of BK Virus Nephropathy (BKVN) in Renal Transplant RecipientsRelationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantationsCross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.BK viremia in critically ill surgical patients with hemorrhagic or septic shock.Ureteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney TransplantationValidation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers.Characterization of T Antigens, Including Middle T and Alternative T, Expressed by the Human Polyomavirus Associated with Trichodysplasia Spinulosa.Seroepidemiology of Human Polyomaviruses in a US Population.BK virus nephropathy in renal transplant recipients.Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition.
P2860
Q21285083-C6FA142C-45BA-4B63-BCBB-355EF4C22FA1Q24653900-37A808CA-A4E7-4762-AEA0-B91897E1C0DCQ26747506-B5B3C167-BD9B-4C8D-85FF-AA995ED8914FQ26751556-0121EA7A-D373-4CD6-A41A-0F67D11CCB8BQ26764877-61EF75E9-E2BF-434F-8343-2203C4E67226Q26773238-1741F5CE-40A9-4FD8-8658-0D47EC3CD925Q26826085-31D5BC86-D2C5-4239-916A-94AA3367CD2DQ26853697-71383BB7-34C3-4C8A-9C20-DB7A68C7282FQ26864381-2E7DCF35-E0AF-4BC6-B85C-C5FBDBE47943Q28069336-06A38FA4-37C5-4497-BDA4-9D4338A5C40EQ28070240-C42576D4-2946-4978-9651-E324501F8A97Q28080994-5DB1D59A-CE20-43E2-86A0-72AD64430EC3Q28085440-92EC03BB-6C0D-4C26-A1DE-B7C1E1121558Q28292658-F0A227F7-B6E3-4F4A-9646-FC9B759E3C4CQ28294236-F593A86E-21BF-4BA1-B320-4D3177F21B91Q28388806-EDCF6C9C-8BD9-4BFD-ACFC-5149CB79AF06Q28510308-B3FDCE7A-C172-462F-8743-9A69ECD9BECDQ30224990-3886EC62-322E-422A-9552-D952CB5939FEQ30422449-108DAC86-F461-4EE3-9DDE-3CB791689B50Q33376066-06F97DEC-EC92-4B65-AE47-6DE2AB22474CQ33383793-3450BC7A-FD74-4EA2-8723-3403CDFE8F46Q33423115-F887178F-DD4B-4314-8393-DE823A5D8028Q33574532-A8BBB26D-3D13-4C97-BE1F-8F8C8411BBD1Q33620674-C368CF05-5ABE-44C4-9B87-E6E14AC18634Q33668087-A631EA2A-D885-47DA-9B62-9AED2967829CQ33694700-CB7F8F1A-F19B-49DF-BE17-7826D9413369Q33745763-02A50AB5-3709-4C07-927E-4F007F28A31AQ33781206-6BEA6821-316B-43A8-9331-2406CDF5DB84Q33793057-6F53B162-20B9-4A24-B8A5-467ECD9FC53FQ33871893-86533888-BA69-4B2A-81C9-08671BC4B043Q33905299-23CD131B-30B3-482B-BCDE-4A080BA2EEEEQ33930455-59E6CDB9-7AF2-4011-8E29-C3F31998BFD6Q34160431-53673835-5AB2-40D0-8993-184AF5FDAFF3Q34257069-80C223DE-ED64-4CC0-8E1C-EDBD2B330540Q34337472-A97EAE38-5A6F-406D-8EF3-0F7333516C88Q34483309-BF176556-D5CB-4CDB-8E8B-BA9B0EB7DDF8Q34505098-E0385487-6C2C-4261-B590-8B5BFB7BD406Q34509585-4E2A448C-4387-4ECB-98C6-A9FBC54EDAF7Q34545686-D3CF19BF-F85D-43D1-9F92-E8DB09C7CE6CQ35006676-E4442F20-7C3C-4376-AFBB-E36F37BBE606
P2860
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Prospective study of polyomavi ...... n renal-transplant recipients.
@en
Prospective study of polyomavi ...... n renal-transplant recipients.
@nl
type
label
Prospective study of polyomavi ...... n renal-transplant recipients.
@en
Prospective study of polyomavi ...... n renal-transplant recipients.
@nl
prefLabel
Prospective study of polyomavi ...... n renal-transplant recipients.
@en
Prospective study of polyomavi ...... n renal-transplant recipients.
@nl
P2093
P356
P1476
Prospective study of polyomavi ...... n renal-transplant recipients.
@en
P2093
Hans H Hirsch
Jakob Passweg
Jürg Steiger
Michael Dickenmann
Michael J Mihatsch
Wendy Knowles
P304
P356
10.1056/NEJMOA020439
P407
P577
2002-08-01T00:00:00Z